Filing Flows › Ceribell (CBLL) › Q2 2026 › vs Q1 2026
Ceribell (CBLL) Q2 2026 vs Q1 2026 (quarter over quarter)
Ceribell's revenue rose $1.6M (+6%) from $26.5M in Q1 2026 to $28.1M in Q2 2026. The biggest changes: Product +$1.1M (+5%); Subscription +$552K (+9%).
Ceribell, Q2 2026: revenue $28.1M (+32% year over year), operating margin -71.1%, net loss $19.3M, operating cash flow −$12.9M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Product | $21.2M | $20.2M | $1.1M | +5% |
| Subscription | $6.9M | $6.3M | $552K | +9% |
| Revenue | $28.1M | $26.5M | $1.6M | +6% |
| Other income, net | $713K | $1.0M | −$295K | -29% |
| Net loss | $19.3M | $19.7M | −$469K | -2% |
| Costs & expenses | $48.1M | $47.2M | $839K | +2% |
| Operating costs | $48.1M | $47.2M | $839K | +2% |
| Cost of revenue | $2.2M | $3.4M | −$1.2M | -36% |
| Research & development | $6.7M | $6.2M | $586K | +10% |
| Sales & marketing | $24.4M | $22.4M | $2.0M | +9% |
| General & admin | $14.8M | $15.3M | −$559K | -4% |
| Operating cash sources | $19.3M | $19.7M | −$469K | -2% |
| Depreciation & amortization | $245K | $239K | $6K | +3% |
| Share-based compensation | $6.0M | $3.7M | $2.3M | +61% |
| Working capital & other | $162K | −$3.5M | $3.7M | — |
| Cash used in operations | $12.9M | $19.3M | −$6.4M | -33% |
| Net loss absorbed | $19.3M | $19.7M | −$469K | -2% |
Questions
How much did Ceribell's revenue grow quarter over quarter in Q2 2026?
Ceribell's revenue rose $1.6M (+6%) from $26.5M in Q1 2026 to $28.1M in Q2 2026.
What drove Ceribell's revenue change in Q2 2026?
Product +$1.1M (+5%); Subscription +$552K (+9%).